Robertson Stephen P.
Robertson Stephen P., CLO, reported an open-market or private sale at Aurinia Pharmaceuticals Inc. involving 20975.000000 shares for an estimated $355945.75. Reported holdings after the transaction were 600787.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 21, 2026
- Filing date
- Aug 26, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 621,762 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
AUPH price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001837798-26-000013 Common Stock
- Transaction date
- Aug 21, 2026 Filed Aug 26, 2026, 01:29 AM · 5d delay
- Shares
- 20,975 sh $16.97 per share
- Estimated value
- -$355k Computed from shares × price
- Holdings after
- 600,787 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Legal Officer
- F1
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance aw…
- F2
The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.04, inclusive. The reporting person undertakes to provide to the…
- F3
Includes 360 common shares that were acquired on May 29, 2026 by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan.
0 other transactions
0 recent txs